Calibre Chemicals takes over R&D activities of Tina Life Sciences
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
Essex enriches and complements Emmes’ services
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Proposed combination enhances Pfizer’s position as a leading company in oncology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
The business serves the healthcare and laboratory sectors on the west coast of the United States.
Subscribe To Our Newsletter & Stay Updated